Context-dependent reconfiguration and spatial reorganisation of the miR-199a-5p/XIAP axis in high-grade serous ovarian cancer
Teresa Muñoz‐GaldeanoiD, David ReigadaiD, Manuel Nieto‐DíaziD, Magda Palka-KotlowskaiD, Lorena Gonzalez GeaiD, María García Peña, Belén SantacruziD, Guillermo IglesiasiD, Rodrigo M. MazaiD
Abstract
BackgroundHigh-grade serous ovarian cancer (HGSOC) is a leading cause of gynaecological cancer mortality, largely because of late diagnosis and platinum resistance. Impaired apoptotic execution is a defining feature of resistant disease, but the regulatory interactions underlying this phenotype remain incompletely understood. The relationship between miR-199a-5p and the anti-apoptotic factor XIAP across cisplatin-sensitive and cisplatin-resistant states was the focus of this study. MethodsWe investigated the miR-199a-5p/XIAP axis in paired cisplatin-sensitive (A2780) and cisplatin-resistant (A2780cis) ovarian cancer models and in human ovarian tissue using multiplex fluorescence in situ hybridisation and immunofluorescence. ResultsmiR-199a-5p did not show a uniform repressive relationship with XIAP across cellular states. In sensitive cells, miR-199a-5p was consistent with basal XIAP repression and enhanced apoptotic responses following cisplatin exposure. In resistant cells, this relationship was attenuated, suggesting uncoupling between XIAP and apoptotic responsiveness after cisplatin. In human FFPE specimens, spatial analysis identified tumour-associated reorganisation of this axis, with broader miR-199a-5p distribution, greater overlap with XIAP, and a distinct perinuclear pattern in HGSOC. ConclusionsThe miR-199a-5p/XIAP axis is context-dependent and altered in cisplatin-resistant ovarian cancer. These findings support spatially resolved analysis as a useful framework for identifying regulatory heterogeneity and tumour-associated phenotypes linked to platinum-resistant disease.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms
Elena Lomonosova, Megan Loeb, … Mary Margaret Mullen·bioRxiv·Aug 4, 2025
- The miR-221-5p/RAD18/RAD51 axis regulates DNA damage tolerance and homologous recombination to drive platinum resistance in ovarian cancer.
Tasmin Rahman Omy, Naresh Sah, … Komaraiah Palle·bioRxiv·May 14, 2026
- Convergent stromal and immune remodeling defines spatial tumor dynamics in PARP inhibitor-resistant high-grade serous ovarian cancer
Kathleen J. Imbach, Sergi Cervilla, … Jordi G Barretina·bioRxiv·Mar 5, 2026
- Platinum-Induced Mitochondrial OXPHOS Contributes to Cancer Stem Cell Enrichment in Ovarian Cancer
S. Sriramkumar, R. Sood, … H. M. OHagan·Journal of Translational MedicinePeer-reviewed·May 31, 2022
- HSPA8-mediated stability of the CLPP protein regulates mitochondrial autophagy in cisplatin-resistant ovarian cancer cells
- The MEK1/2 pathway as a therapeutic target in high-grade serous ovarian carcinoma
M. Chesnokov, I. Khan, … I. Chefetz Menaker·bioRxiv·Sep 16, 2019